Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase NA 4Phase EARLY_PHASE1 4Phase 1 4Phase 1/2 3Phase 4 2Phase 3 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 4FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 3Thoracic 1

Conditions

Carcinoma, Basal Cell 3Skin Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Itraconazole × Clear all
NCT02357836 2021-05-03

Neoadjuvant Itraconazole in Non-small Cell Lung Cancer

University of Texas Southwestern Medical Center

Phase EARLY_PHASE1 Completed
13 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02120677 2020-12-16

Topical Itraconazole in the Treatment of Basal Cell Carcinoma

Johns Hopkins University

Phase EARLY_PHASE1 Completed
5 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT02699723 2020-10-22

Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer

Stanford University

Phase EARLY_PHASE1 Withdrawn
Dermatologic

Carcinoma, Basal Cell

NCT02735356 2019-04-11

Topical Itraconazole in Treating Patients With Basal Cell Cancer

Stanford University

Phase EARLY_PHASE1 Completed
9 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡